uric acid has been researched along with Exanthem in 5 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A dosage of 300 mg/d of allopurinol was not effective in reducing pain or improving activities of daily living in chronic pancreatitis." | 9.08 | Does allopurinol reduce pain of chronic pancreatitis? ( Banks, PA; Ferrante, M; Hughes, M; Noordhoek, EC; Ramagopal, V; Slivka, A, 1997) |
| "Benzbromarone provides useful urate-lowering efficacy and does not appear unsafe in patients with gout." | 7.83 | The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand. ( Cathro, A; Corkill, M; Dalbeth, N; Frampton, C; Gardner, D; Grainger, R; Haslett, J; Kain, T; Kumar, R; Kumar, S; Metcalfe, S; Porter, D; Stamp, LK; Stebbings, S; Taylor, G; White, D; Wyeth, J, 2016) |
| "A dosage of 300 mg/d of allopurinol was not effective in reducing pain or improving activities of daily living in chronic pancreatitis." | 5.08 | Does allopurinol reduce pain of chronic pancreatitis? ( Banks, PA; Ferrante, M; Hughes, M; Noordhoek, EC; Ramagopal, V; Slivka, A, 1997) |
| "Benzbromarone provides useful urate-lowering efficacy and does not appear unsafe in patients with gout." | 3.83 | The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand. ( Cathro, A; Corkill, M; Dalbeth, N; Frampton, C; Gardner, D; Grainger, R; Haslett, J; Kain, T; Kumar, R; Kumar, S; Metcalfe, S; Porter, D; Stamp, LK; Stebbings, S; Taylor, G; White, D; Wyeth, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stamp, LK | 1 |
| Haslett, J | 1 |
| Frampton, C | 1 |
| White, D | 1 |
| Gardner, D | 1 |
| Stebbings, S | 1 |
| Taylor, G | 1 |
| Grainger, R | 1 |
| Kumar, R | 1 |
| Kumar, S | 1 |
| Kain, T | 1 |
| Porter, D | 1 |
| Corkill, M | 1 |
| Cathro, A | 1 |
| Metcalfe, S | 1 |
| Wyeth, J | 1 |
| Dalbeth, N | 1 |
| Yang, Z | 1 |
| Liang, Y | 1 |
| Li, C | 1 |
| Xi, W | 1 |
| Zhong, R | 1 |
| Banks, PA | 1 |
| Hughes, M | 1 |
| Ferrante, M | 1 |
| Noordhoek, EC | 1 |
| Ramagopal, V | 1 |
| Slivka, A | 1 |
| Shionoiri, H | 1 |
| Sugimoto, K | 1 |
| Kosaka, T | 1 |
| Kita, E | 1 |
| Oda, H | 1 |
| Ushikubo, T | 1 |
| Goto, T | 1 |
| Takasaki, I | 1 |
| Yasuda, G | 1 |
| Holmes, EL | 1 |
3 trials available for uric acid and Exanthem
| Article | Year |
|---|---|
Does allopurinol reduce pain of chronic pancreatitis?
Topics: Abdominal Pain; Activities of Daily Living; Adult; Allopurinol; Ankle; Blood Cell Count; Chronic Dis | 1997 |
Long-term therapy with an ACE inhibitor, temocapril, reduces microalbuminuria in essential hypertension.
Topics: Albuminuria; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cough; | 1998 |
Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Biphenyl Compounds; Blood Coagulation; Blood Urea Nitrogen | 1966 |
2 other studies available for uric acid and Exanthem
| Article | Year |
|---|---|
The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
Topics: Aged; Allopurinol; Benzbromarone; Comorbidity; Exanthema; Female; Gout; Gout Suppressants; Humans; K | 2016 |
Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus.
Topics: Arthritis; Biomarkers; China; Comorbidity; Creatinine; Exanthema; Female; Humans; Logistic Models; L | 2012 |